MicroRNA-203 Is a Prognostic Indicator in Bladder Cancer and Enhances Chemosensitivity to Cisplatin via Apoptosis by Targeting Bcl-w and Survivin

• Xin Zhang,

  Affiliation Department of Clinical Laboratory, Qilu Hospital, Shandong University, Jinan, China

  ⨯
• Yanli Zhang,

  Affiliation Department of Clinical Laboratory, Traffic Hospital of Shandong Province, Jinan, China

  ⨯
• Xinfeng Liu,

  Affiliation Department of Clinical Laboratory, Traffic Hospital of Shandong Province, Jinan, China

  ⨯
• Aiju Fang,

  Affiliation Department of Pathology, Traffic Hospital of Shandong Province, Jinan, China

  ⨯
• Peilong Li,

  Affiliation Department of Clinical Laboratory, Qilu Hospital, Shandong University, Jinan, China

  ⨯
• Zewu Li,

  Affiliation Department of Clinical Laboratory, Qilu Hospital, Shandong University, Jinan, China

  ⨯
• Tong Liu,

  Affiliation Department of Clinical Laboratory, Qilu Hospital, Shandong University, Jinan, China

  ⨯
• Yongmei Yang,

  Affiliation Department of Clinical Laboratory, Qilu Hospital, Shandong University, Jinan, China

  ⨯
• Lutao Du,

  Affiliation Department of Clinical Laboratory, Qilu Hospital, Shandong University, Jinan, China

  ⨯
• Chuanxin Wang

  * E-mail: cxwang@sdu.edu.cn

  Affiliation Department of Clinical Laboratory, Qilu Hospital, Shandong University, Jinan, China

  ⨯